HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025. In the quarter to July 2026, revenue grew 7.64%, EPS grew 14.5%, free cash flow fell 3.44% and total debt fell 7.53%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
Follow HQY
HealthEquity, Inc. (HQY) P/E ratio
As of 16 October 2026, HealthEquity, Inc. (HQY) trades at a P/E ratio of 33.0×. Over the past ten years it has ranged from 0.0× (July 2023) to 7,417× (August 2021); the current reading is higher than 20% of that period. That is below the Health Information Services industry median of 39.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 35.0× | (64.85%) |
| FY2025 | 99.5× | (14.45%) |
| FY2024 | 116× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 711× | 620.70% |
| FY2020 | 98.6× | 88.21% |
| FY2019 | 52.4× | (19.28%) |
| FY2018 | 64.9× | (36.86%) |
| FY2017 | 103× | 40.13% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 36.1× | 18.25% |
| Apr 2026 | 30.5× | (12.79%) |
| Jan 2026 | 35.0× | (18.29%) |
| Oct 2025 | 42.8× | (25.88%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| TXG 10x Genomics compare | n/m |
| HQY HealthEquity, Inc. | 33.0× |
| BTSG BrightSpring Health Services, Inc. compare | 34.0× |
| DOCS Doximity, Inc. compare | 34.8× |
| WAY Waystar Holding Corp. compare | 38.0× |
| HNGE Hinge Health Inc. compare | 73.5× |
| PRVA Privia Health Group, Inc. compare | 102× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)